The World Health Organization (WHO) classification of the myeloid neoplasms
about
sameAs
Deferasirox for managing iron overload in people with myelodysplastic syndromeAntiplatelet drugs for polycythaemia vera and essential thrombocythaemiaDeferasirox for managing iron overload in people with myelodysplastic syndromeThe role of colony stimulating factors administered for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaDeferasirox for managing iron overload in patients with myelodysplastic syndromeAntiplatelet drugs for polycythaemia vera and essential thrombocythaemiaAntiplatelet drugs for polycythemia vera and essential thrombocythaemiaDido gene expression alterations are implicated in the induction of hematological myeloid neoplasmsPrevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasmsClinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsDecitabine in the treatment of myelodysplastic syndromesAbnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosisFrom cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formationThe Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyDual effect of oxidative stress on leukemia cancer induction and treatmentPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsChronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and managementA common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemiaThe structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiationTherapy-related myeloid neoplasms - what have we learned so far?Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literatureMDS prognostic scoring systems – past, present, and futureReticuloendothelial malignancy of head and neck: A comprehensive reviewIdentification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genesPhenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosisRecent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.Heralding Extramedullary Blast Crisis: Horner's Syndrome with Brachial Plexopathy in a Patient with Chronic Myelogenous LeukemiaPlatelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission.Resolving and classifying haematopoietic bone-marrow cell populations by multi-dimensional analysis of flow-cytometry data.Solving the mystery of myelodysplasia.JAK2 V617F in myeloid disorders: what do we know now, and where are we headed?The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.JAK and MPL mutations in myeloid malignancies.Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome.
P2860
Q24193067-9F442993-7627-4E66-9B14-A1DA56830E6CQ24197847-63325FC7-CD79-41E6-A70B-445B901A9F83Q24236532-680FFEA6-1F8C-461B-A301-1BB0B2E07E5CQ24241455-7595B240-E639-4775-BA95-6872DA8D0E8CQ24242437-1B107844-4FAC-4A29-8417-A35D715FB01DQ24242920-371A9924-C316-43DD-A87A-E6F0FFEA8871Q24246098-098C6410-8FCF-4076-8A6E-439DE0DACFD3Q24530021-A6E2A282-C90F-45C6-9F0F-CAC2BFA0E3AFQ24595117-8829CAD7-7692-4686-B019-EF94C047AC00Q24629306-98DB007D-A5C8-4704-8074-094F15AADFD1Q24641906-E022EAFD-2DDD-419A-B995-4B578CAF86F3Q24671505-75ABA4C5-B4E6-437D-AA7C-4E44D91CE363Q26786192-9D9F346E-9BF3-4B7D-B70A-DE49E47789D3Q26799596-FD760A22-4483-4228-83FE-FF31F13B8168Q26866544-2876F035-6F2D-4B0F-B7D7-30AC1C31626BQ26991440-B86FCD01-5BB6-4558-AF9E-1290DAB9DD1AQ27009366-D69B47B8-0FAE-4A01-92FF-635877B8EB52Q27321277-AFC3FD43-A3E8-4CE3-A1A7-C584B8447E77Q27666639-75AC69F3-2549-4935-A7D5-8F22AAC8B7F8Q28071318-527C4DA1-D3D7-4E4E-A377-C7367EB2EEE5Q28076710-D26AA3BF-59AE-4F48-8FAA-83118D1BE8CBQ28082460-7F6C61A7-FD88-46B7-919C-E9EDE530E8FDQ28084523-E5C1C716-69B4-4A23-9DEC-D2535BA9F6EBQ28592846-AC302144-895A-4BA3-AD93-0B881F9BE019Q28756161-D1F21ABF-0F76-49DC-9767-D8AAB3EBCE59Q30249108-E1D9A121-33CC-4149-9545-B19C3476FACAQ30274942-3E664DBA-8C9D-4377-89CF-4C3EC60612FAQ30833663-6C637DF0-B13C-4719-A230-BD9D88A09DF1Q30838366-3EC39EA1-2830-4E47-B0E0-BC8938030AC3Q30987705-8FBA3968-D431-4ED9-B556-1FE12F44C825Q33319613-21DC271C-5559-46F5-84A6-BBAA3FBF4C7EQ33341856-1892E729-4000-481A-8803-112F27A44D88Q33365634-809942F8-AC6D-4A35-BB8A-9AE2400929A6Q33370159-4B2A8907-6131-4B52-8C7F-E02A9E0AFDCBQ33377270-BD2A555A-4B01-430B-963D-1B017BB9F9B4Q33378737-5F17FA8A-DC57-4B98-A125-57661D8490FCQ33382047-12296BA5-2DE2-4FD7-9058-C59578CB5691Q33392366-C6024DC3-E722-4593-BF68-0492678D13F1Q33393647-439FB622-1A7B-4F99-813A-D3FFACEF0CE3Q33395648-C550336F-7507-461B-B2A0-8CD6F18CD78F
P2860
The World Health Organization (WHO) classification of the myeloid neoplasms
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The World Health Organization (WHO) classification of the myeloid neoplasms
@ast
The World Health Organization (WHO) classification of the myeloid neoplasms
@en
The World Health Organization (WHO) classification of the myeloid neoplasms
@nl
type
label
The World Health Organization (WHO) classification of the myeloid neoplasms
@ast
The World Health Organization (WHO) classification of the myeloid neoplasms
@en
The World Health Organization (WHO) classification of the myeloid neoplasms
@nl
prefLabel
The World Health Organization (WHO) classification of the myeloid neoplasms
@ast
The World Health Organization (WHO) classification of the myeloid neoplasms
@en
The World Health Organization (WHO) classification of the myeloid neoplasms
@nl
P2093
P3181
P1433
P1476
The World Health Organization (WHO) classification of the myeloid neoplasms
@en
P2093
James W Vardiman
Nancy Lee Harris
Richard D Brunning
P304
P3181
P356
10.1182/BLOOD-2002-04-1199
P407
P577
2002-10-01T00:00:00Z